British drugmaker GlaxoSmithKline PLC is making major changes in its spending on training programs for doctors, fees paid to doctors for consulting, and even political contributions. The changes include immediate bans on all corporate political contributions and on using commercial medical education and communication companies to run programs teaching doctors...
more »